Isoniazid Market Drivers: Rising Tuberculosis Cases and Demand for First-Line Anti-TB Drugs Worldwide
The global Isoniazid market is anticipated to witness steady expansion through 2031 as tuberculosis continues to remain a major global health challenge. Rising awareness about infectious disease prevention, growing access to healthcare services, and strong public health initiatives are driving sustained demand for first-line anti-tuberculosis medications. The market is projected to grow at a...
0 Комментарии 0 Поделились 101 Просмотры 0 предпросмотр